NYSE - BOATS Real Time Price USD
Hims & Hers Health, Inc. (HIMS)
32.70 -0.26 (-0.79%)
At close: June 24 at 4:00:03 PM EDT
32.96 +0.26 (+0.80%)
Overnight: 3:34:50 AM EDT
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Trade HIMS on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for HIMS
Chart does not reflect overnight price.
- Previous Close
32.96 - Open
32.60 - Bid --
- Ask --
- Day's Range
31.62 - 33.74 - 52 Week Range
13.74 - 70.43 - Volume
11,225,435 - Avg. Volume
25,767,416 - Market Cap (intraday)
7.569B - Beta (5Y Monthly) 2.40
- PE Ratio (TTM)
-- - EPS (TTM)
-0.09 - Earnings Date (est.) Aug 10, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
27.32
Recent News
View More
Performance Overview
Trailing total returns as of 6/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
HIMS
0.71%
S&P 500 (^GSPC)
7.49%
1-Year Return
HIMS
23.86%
S&P 500 (^GSPC)
20.78%
3-Year Return
HIMS
288.36%
S&P 500 (^GSPC)
69.22%
5-Year Return
HIMS
204.19%
S&P 500 (^GSPC)
72.47%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/23/2026
Market Cap
7.63B
Enterprise Value
8.01B
Trailing P/E
57.14
Forward P/E
58.82
PEG Ratio (5yr expected)
2.15
Price/Sales (ttm)
3.53
Price/Book (mrq)
17.10
Enterprise Value/Revenue
3.38
Enterprise Value/EBITDA
213.19
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.56%
Return on Assets (ttm)
0.60%
Return on Equity (ttm)
-2.66%
Revenue (ttm)
2.37B
Net Income Avi to Common (ttm)
-13.23M
Diluted EPS (ttm)
-0.09
Balance Sheet and Cash Flow
Total Cash (mrq)
750.88M
Total Debt/Equity (mrq)
253.73%
Levered Free Cash Flow (ttm)
174.31M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
32.70
-0.79%
Mkt Cap 7.569B
Industry Drug Manufacturers—Specialty & Generic
8.56
-22.74%
Mkt Cap 4.233B
Industry Drug Manufacturers—Specialty & Generic
4.9900
-0.80%
Mkt Cap 625.996M
Industry Drug Manufacturers—Specialty & Generic
34.22
+3.04%
Mkt Cap 39.847B
Industry Drug Manufacturers—Specialty & Generic
4.5900
-0.43%
Mkt Cap 554.556M
Industry Drug Manufacturers—Specialty & Generic
0.9217
-2.59%
Mkt Cap 413.305M
Industry Drug Manufacturers—Specialty & Generic
2.5400
+2.42%
Mkt Cap 11.324M
Industry Drug Manufacturers—Specialty & Generic
2.8300
-0.70%
Mkt Cap 175.296M
Industry Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View MoreRaising target price to $31.00
HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $30.00
HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $30.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetHims Earnings: Soft Start to the Year as We Wait to See Full Benefits of Novo Partnership
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
RatingPrice TargetRaising target price to $28.00
HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $28.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target